Related references
Note: Only part of the references are listed.Differential ex vivo and in vivo endotoxin tolerance kinetics following human endotoxemia
Matthijs Kox et al.
CRITICAL CARE MEDICINE (2011)
Immunosuppression in Patients Who Die of Sepsis and Multiple Organ Failure
Jonathan S. Boomer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
The late phase of sepsis is characterized by an increased microbiological burden and death rate
Gordon P. Otto et al.
CRITICAL CARE (2011)
Granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) for sepsis: a meta-analysis
Lulong Bo et al.
CRITICAL CARE (2011)
Changes of monocyte human leukocyte antigen-DR expression as a reliable predictor of mortality in severe sepsis
Jian-Feng Wu et al.
CRITICAL CARE (2011)
Characterization and Modulation of the Immunosuppressive Phase of Sepsis
Jared T. Muenzer et al.
INFECTION AND IMMUNITY (2010)
Lipopolysaccharide-stimulated whole blood cytokine production does not predict the inflammatory response in human endotoxemia
Mirrin J. Dorresteijn et al.
INNATE IMMUNITY (2010)
Low monocyte human leukocyte antigen-DR is independently associated with nosocomial infections after septic shock
Caroline Landelle et al.
INTENSIVE CARE MEDICINE (2010)
Immunotherapy for Sepsis - A New Approach against an Ancient Foe
Richard S. Hotchkiss et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
IFN-γ abrogates endotoxin tolerance by facilitating Toll-like receptor-induced chromatin remodeling
Janice Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Granulocyte-Macrophage Colony-stimulating Factor to Reverse Sepsis-associated Immunosuppression A Double-Blind, Randomized, Placebo-controlled Multicenter Trial
Christian Meisel et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Monocytic HLA-DR expression in intensive care patients: Interest for prognosis and secondary infection prediction
Anne-Claire Lukaszewicz et al.
CRITICAL CARE MEDICINE (2009)
Development of endotoxin tolerance in humans in vivo
Annelies Draisma et al.
CRITICAL CARE MEDICINE (2009)
In Vivo Lipopolysaccharide Exposure of Human Blood Leukocytes Induces Cross-Tolerance to Multiple TLR Ligands
Alex F. de Vos et al.
JOURNAL OF IMMUNOLOGY (2009)
Tilting toward immunosuppression
Richard S. Hotchkiss et al.
NATURE MEDICINE (2009)
The effect of systemic iNOS inhibition during human endotoxemia on the development of tolerance to different TLR-stimuli
Annelies Draisma et al.
INNATE IMMUNITY (2008)
Reactivation of Cytomegalovirus Infection in Critically Ill Immunocompetent Patients Reply
Ajit P. Limaye et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Diversity of interferon γ and granulocyte-macrophage colony-stimulating factor in restoring immune dysfunction of dendritic cells and macrophages during polymicrobial sepsis
Stefanie B. Flohe et al.
MOLECULAR MEDICINE (2008)
Induction of IRAK-M is associated with lipopolysaccharide tolerance in a human endotoxemia model
Cornelis van 't Veer et al.
JOURNAL OF IMMUNOLOGY (2007)
Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock
Guillaume Monneret et al.
INTENSIVE CARE MEDICINE (2006)
Monitoring temporary immunodepression by flow cytometric measurement of monocytic HLA-DR expression:: A multicenter standardized study
WD Döcke et al.
CLINICAL CHEMISTRY (2005)
Messenger RNA expression of major histocompatibility complex class II genes in whole blood from septic shock patients
A Pachot et al.
CRITICAL CARE MEDICINE (2005)
Monocyte human leukocyte antigen-DR transcriptional downregulation by cortisol during septic shock
Y Le Tulzo et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Is low monocyte HLA-DR expression helpful to predict outcome in severe sepsis?
SE Perry et al.
INTENSIVE CARE MEDICINE (2003)
Predictive value of monocyte histocompatibility leukocyte antigen-DR expression and plasma interleukin-4 and-10 levels in critically ill patients with sepsis
M Hynninen et al.
SHOCK (2003)
IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages
H Yasukawa et al.
NATURE IMMUNOLOGY (2003)
Such stuff as dreams are made on: Mediator-directed therapy in sepsis
JC Marshall
NATURE REVIEWS DRUG DISCOVERY (2003)
Reversal of immunoparalysis by recombinant human granulocyte-macrophage colony-stimulating factor in patients with severe sepsis
A Nierhaus et al.
INTENSIVE CARE MEDICINE (2003)
Medical progress: The pathophysiology and treatment of sepsis.
RS Hotchkiss et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Diminished interferon-γ production and responsiveness after endotoxin administration to healthy humans
S Weijer et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
A randomized phase II trial of granulocyte-macrophage colony-stimulating factor therapy in severe sepsis with respiratory dysfunction
JJ Presneill et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)
Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care
DC Angus et al.
CRITICAL CARE MEDICINE (2001)
Impaired ex vivo lipopolysaccharide-stimulated whole blood tumor necrosis factor production may identify septic intensive care unit patients
W Heagy et al.
SHOCK (2000)
Share Paper
